Summary:
A multicenter, randomized, double-blind, placebo-controlled, phase 3 study to evaluate the efficacy and safety of CB-5945 for the treatment of Opioid-Induced Constipation in adults taking opioid therapy for chronic non-cancer pain.
Qualified Participants Must:
• Have Consipation from opioid usage
Qualified Participants May Receive:
$50 dollars per visit, free Medication and free study healthcare.